Obeda 14mg provides semaglutide in an oral formulation. Semaglutide acts on GLP-1 receptors, helping the body release insulin in response to elevated blood glucose while reducing inappropriate glucagon secretion.

It also slows gastric emptying and can influence appetite, making it part of a broader approach to managing type 2 diabetes. Treatment is generally adjusted gradually to improve tolerability.

Brand: Obeda

Active Ingredient: Semaglutide 14mg

Dosage Form: Tablet

Strength: 14mg

Category: GLP-1 receptor agonist

Route: Oral

Take exactly as directed, particularly regarding administration timing and food restrictions.